Investors who are hesitant about buying shares of Novo Nordisk due to its valuation should consider the potential upside for the stock in the long run. If there are additional indications for Ozempic, ...

The agency received reports of patients taking up to 20 times the prescribed dosage, causing some to be hospitalized.

Novo Nordisk A/S reported a minor fire in the basement of a building at its largest research center, the latest in a series ...

Novo Nordisk — the pharmaceutical giant behind popular weight-loss drugs Ozempic and Wegovy — spent a record $3.2 million on ...

Shares of Novo Nordisk and Eli Lilly slid Thursday after San Diego-based Viking Therapeutics announced that it’s advancing an ...

Novo Nordisk (NYSE: NVO) is under attack. Although the Denmark-based drugmaker is a pioneer and leader in the GLP-1 diabetes ...

Novo Nordisk A/S has secured land and planning permissions for what may be its next major factory site in Denmark as the ...

After filing 13 lawsuits in 2023 claiming trademark infringement, deceptive trade practices, and false advertising related to ...

Novo Nordisk's Wegovy has received backing from the EU's medical regulator to expand the weight loss drug's use to reducing ...

After making major manufacturing outlays in places like China and the United States earlier this year, Novo Nordisk is ...

Despite recent concerns about suicidality and other neuropsychiatric issues, a recent study has found that Novo Nordisk’s ...

Novo Nordisk , the maker of weight-loss drug Wegovy, has bought a site in Denmark's third largest city Odense and begun ...